loadpatents
Patent applications and USPTO patent grants for NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY.The latest application filed is for "antisense nucleic acids".
Patent | Date |
---|---|
Nucleic Acid Delivery Complex App 20220127606A1 - | 2022-04-28 |
Antisense Nucleic Acids App 20210147839 - ENYA; Yukiko ;   et al. | 2021-05-20 |
Oligodendrocyte-specific Promoter, Mirna Specific To Plp1 Gene,vector Including Said Promoter And/or Mirna, And Pharmaceutical Composition Including Said Vector App 20210087560 - Inoue; Ken ;   et al. | 2021-03-25 |
Inducer of muscle differentiation Grant 10,934,543 - Hohjoh , et al. March 2, 2 | 2021-03-02 |
Neonatal Hypoxic-ischemic Encephalopathy Severity Determining Method And Prognosis Predicting Method App 20210041468 - ITO; Masayuki ;   et al. | 2021-02-11 |
Antisense nucleic acids Grant 10,870,676 - Watanabe , et al. December 22, 2 | 2020-12-22 |
Antisense nucleic acids Grant 10,851,373 - Enya , et al. December 1, 2 | 2020-12-01 |
Antisense nucleic acids Grant 10,781,448 - Watanabe , et al. Sept | 2020-09-22 |
Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy Grant 10,782,290 - Yamamura , et al. Sept | 2020-09-22 |
Stem Cells For Transplantation And Manufacturing Method Therefor App 20200222506 - OKADA; TAKASHI ;   et al. | 2020-07-16 |
System, Method, and Program for Predicting Diminished Attentiveness State, and Storage Medium on Which Program Is Stored App 20200218935A1 - | 2020-07-09 |
Method for determining application of therapy to multiple sclerosis (MS) patient Grant 10,697,883 - Yamamura , et al. | 2020-06-30 |
Biomarker For Diagnosing Depression And Use Of Biomarker App 20200191768A1 - | 2020-06-18 |
Antisense nucleic acids Grant 10,683,322 - Watanabe , et al. | 2020-06-16 |
Antisense nucleic acids Grant 10,662,217 - Watanabe , et al. | 2020-05-26 |
Method For Predicting And Evaluating Therapeutic Effect In Diseases Related To Il-6 And Neutrophils App 20200148760A1 - | 2020-05-14 |
Antisense Nucleic Acids App 20200149040A1 - | 2020-05-14 |
Antisense nucleic acids Grant 10,647,741 - Watanabe , et al. | 2020-05-12 |
Antisense Nucleic Acids App 20200115411A1 - | 2020-04-16 |
Agent For Improving Brain Function And Agent For Preventing Or Treating Cognitive Impairment App 20200108040A1 - | 2020-04-09 |
Antisense Nucleic Acids App 20200109162A1 - | 2020-04-09 |
Antisense Nucleic Acids App 20200102343 - WATANABE; Naoki ;   et al. | 2020-04-02 |
Prophylactic Agent, Onset-suppressing Agent Or Therapeutic Agent For Progressive Immune Demyelinating Diseases App 20200071408 - OKI; Shinji ;   et al. | 2020-03-05 |
Method For Detecting Mood Disorders App 20200024663 - NAKAMURA; Seiji ;   et al. | 2020-01-23 |
Mutant Of Adeno-associated Virus (aav) Capsid Protein App 20200002384 - OKADA; Takashi ;   et al. | 2020-01-02 |
Antisense nucleic acids Grant 10,487,106 - Watanabe , et al. Nov | 2019-11-26 |
Inducer Of Muscle Differentiation (as Amended) App 20190330627 - HOHJOH; Hirohiko ;   et al. | 2019-10-31 |
Antisense Nucleic Acids App 20190315796 - WATANABE; Naoki ;   et al. | 2019-10-17 |
Antisense nucleic acids Grant 10,407,461 - Watanabe , et al. Sept | 2019-09-10 |
Antisense nucleic acids Grant 10,385,092 - Watanabe , et al. A | 2019-08-20 |
Antisense Nucleic Acids App 20190218244 - Watanabe; Naoki ;   et al. | 2019-07-18 |
Antisense Nucleic Acids App 20190211049 - WATANABE; Naoki ;   et al. | 2019-07-11 |
Antisense Nucleic Acids App 20190211050 - WATANABE; Naoki ;   et al. | 2019-07-11 |
Antisense nucleic acids Grant 10,329,319 - Watanabe , et al. | 2019-06-25 |
Antisense Nucleic Acids App 20190040387 - ENYA; Yukiko ;   et al. | 2019-02-07 |
Biomarker For Diagnosing Depression And Use Of Said Biomarker App 20180348195 - KATO; Takahiro ;   et al. | 2018-12-06 |
Antisense nucleic acids Grant 10,144,931 - Enya , et al. De | 2018-12-04 |
Stem Cells For Transplantation And Manufacturing Method Therefor App 20180333462 - OKADA; Takashi ;   et al. | 2018-11-22 |
Stem Cells For Transplantation And Manufacturing Method Therefor App 20180333463 - OKADA; Takashi ;   et al. | 2018-11-22 |
Antisense Nucleic Acids App 20180265866 - ENYA; Yukiko ;   et al. | 2018-09-20 |
Autoimmune Disease Diagnosis Method, Autoimmune Disease Diagnosis Biomarker, And Autoimmune Disease Preventing Or Treating Agent App 20180245138 - YAMAMURA; Takashi ;   et al. | 2018-08-30 |
Therapeutic Agent For Mental Illness Comprising Il-6 Inhibitor As Active Ingredient App 20180186887 - KUNUGI; Hiroshi ;   et al. | 2018-07-05 |
Antisense Nucleic Acids App 20180179538 - Wakayama; Tatsushi ;   et al. | 2018-06-28 |
Agent For Improving Brain Function And Agent For Preventing Or Treating Cognitive Impairment App 20180169052 - KUNUGI; Hiroshi ;   et al. | 2018-06-21 |
Antisense nucleic acids Grant 9,988,629 - Wakayama , et al. June 5, 2 | 2018-06-05 |
Method For Determining Application Of Novel Therapy To Multiple Sclerosis (ms) Patient App 20180149573 - Yamamura; Takashi ;   et al. | 2018-05-31 |
Agent Containing Imidazole Dipeptide App 20180140655 - Hisatsune; Tatsuhiro ;   et al. | 2018-05-24 |
Antisense Nucleic Acids App 20180142245 - WATANABE; Naoki ;   et al. | 2018-05-24 |
Biomarker For Mental Disease App 20180100177 - KUNUGI; Hiroshi ;   et al. | 2018-04-12 |
Morphinan Derivative App 20180057493 - NAGASE; Hiroshi ;   et al. | 2018-03-01 |
Antisense Nucleic Acids App 20180044675 - WATANABE; Naoki ;   et al. | 2018-02-15 |
Antisense nucleic acids Grant 9,890,381 - Watanabe , et al. February 13, 2 | 2018-02-13 |
Cognitive function testing system, cognitive function estimation system, cognitive function testing method, and cognitive function estimation method Grant 9,848,811 - Yasumura , et al. December 26, 2 | 2017-12-26 |
Antisense nucleic acids Grant 9,840,706 - Watanabe , et al. December 12, 2 | 2017-12-12 |
Muscular Dystrophy Therapeutic Agent Containing Pluripotent Stem Cells Derived From Dental Pulp App 20170327791 - OKADA; Takashi ;   et al. | 2017-11-16 |
Antisense Nucleic Acids App 20170320903 - WATANABE; Naoki ;   et al. | 2017-11-09 |
Antisense Nucleic Acids App 20170204410 - WATANABE; Naoki ;   et al. | 2017-07-20 |
Antisense nucleic acids Grant 9,708,361 - Watanabe , et al. July 18, 2 | 2017-07-18 |
Drug Delivery Particle and Method for Producing the Same App 20170172936 - Okada; Takashi ;   et al. | 2017-06-22 |
Agent Containing Imidazole Dipeptide App 20170165314 - Hisatsune; Tatsuhiro ;   et al. | 2017-06-15 |
GM-CSF-PRODUCING T-CELL CONTROL AGENT AND Th1/Th2 IMMUNE BALANCE REGULATOR App 20170151270 - YAMAMURA; Takashi ;   et al. | 2017-06-01 |
Drug delivery particle and method for producing the same Grant 9,610,354 - Okada , et al. April 4, 2 | 2017-04-04 |
Antisense Nucleic Acids App 20170067052 - WATANABE; Naoki ;   et al. | 2017-03-09 |
Antisense Nucleic Acids App 20170067048 - WAKAYAMA; Tatsushi ;   et al. | 2017-03-09 |
Antisense nucleic acids Grant 9,512,424 - Watanabe , et al. December 6, 2 | 2016-12-06 |
Method For Predicting Post-therapy Prognosis Of Relapsing-remitting Multiple Sclerosis (rrms) Patient, And Method For Determining Applicability Of Novel Therapy App 20160139117 - Yamamura; Takashi ;   et al. | 2016-05-19 |
Stem Cells For Transplantation And Manufacturing Method Therefor App 20160089421 - OKADA; Takashi ;   et al. | 2016-03-31 |
Method For Alleviating Fear Memory App 20150272918 - SEKIGUCHI; Masayuki ;   et al. | 2015-10-01 |
Method for alleviating fear memory Grant 9,107,891 - Sekiguchi , et al. August 18, 2 | 2015-08-18 |
Marker For Detecting Myogenic Disease And Detection Method Using The Same App 20150211069 - Hashido; Kazuo ;   et al. | 2015-07-30 |
Antisense nucleic acids Grant 9,079,934 - Watanabe , et al. July 14, 2 | 2015-07-14 |
Antisense Nucleic Acids App 20150166995 - WATANABE; Naoki ;   et al. | 2015-06-18 |
Cognitive Function Testing System, Cognitive Function Estimation System, Cognitive Function Testing Method, And Cognitive Function Estimation Method App 20150119731 - Yasumura; Akira ;   et al. | 2015-04-30 |
Antisense Nucleic Acids App 20140343266 - Watanabe; Naoki ;   et al. | 2014-11-20 |
Method For Alleviating Fear Memory App 20140121276 - Sekiguchi; Masayuki ;   et al. | 2014-05-01 |
Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases Grant 8,658,390 - Urade , et al. February 25, 2 | 2014-02-25 |
Drug Delivery Particle and Method for Producing the Same App 20140044794 - Okada; Takashi ;   et al. | 2014-02-13 |
Antisense Nucleic Acids App 20130211062 - Watanabe; Naoki ;   et al. | 2013-08-15 |
Agent For Suppressing Expression Of Dominant Allele App 20130090373 - Hohjoh; Hirohiko ;   et al. | 2013-04-11 |
Molecular Marker For Evaluating Pathological Conditions And Treatment Of Muscular Dystrophy App 20120329046 - Takeda; Shin'ichi ;   et al. | 2012-12-27 |
Method For Generating Homoplasmic Cells From Heteroplasmic Cells App 20120040464 - Ling; Feng ;   et al. | 2012-02-16 |
Method For Detecting Muscle Degenerative Diseases, And Method For Determining Therapeutic Efficacy On The Diseases App 20110318764A1 - | 2011-12-29 |
Method for assisting in diagnosis of cerebral diseases and apparatus thereof App 20090252391 - Matsuda; Hiroshi ;   et al. | 2009-10-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.